Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Tubercle
|
September 1, 1976
Sepcific tubercle antigen
E Nassau, A E Nelstrop
British Journal of Experimental Pathology
|
February 1, 1970
The detection by immunofluorescence of casein in rat mammary glands
S Young, A E Nelstrop
Comparative Biochemistry and Physiology
|
July 1, 1970
Comparative studies of serum and haemolymph proteins
A E Nelstrop, G Taylor, P Collard
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
T Meyer, A E Nelstrop, M Mahmoudi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1997
A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study
H E Lambert, G J Rustin, W M Gregory, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1996
Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study
G J Rustin, A E Nelstrop, M K Tuxen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels
G J Rustin, M Marples, A E Nelstrop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1993
A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study
H E Lambert, G J Rustin, W M Gregory, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
February 24, 2001
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer
M K Tuxen, G Sölétormos, G J Rustin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2004
Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population
H E Lambert, W M Gregory, A E Nelstrop, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Tubercle
|
September 1, 1976
Sepcific tubercle antigen
E Nassau, A E Nelstrop
British Journal of Experimental Pathology
|
February 1, 1970
The detection by immunofluorescence of casein in rat mammary glands
S Young, A E Nelstrop
Comparative Biochemistry and Physiology
|
July 1, 1970
Comparative studies of serum and haemolymph proteins
A E Nelstrop, G Taylor, P Collard
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
T Meyer, A E Nelstrop, M Mahmoudi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1997
A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study
H E Lambert, G J Rustin, W M Gregory, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1996
Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study
G J Rustin, A E Nelstrop, M K Tuxen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2001
Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels
G J Rustin, M Marples, A E Nelstrop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1993
A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study
H E Lambert, G J Rustin, W M Gregory, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
February 24, 2001
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer
M K Tuxen, G Sölétormos, G J Rustin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2004
Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population
H E Lambert, W M Gregory, A E Nelstrop, et al.
Page
of 2